241 results on '"Mentz, Robert J"'
Search Results
2. Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEF
3. Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction
4. Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction
5. Regional variation in cause of death in patients with type 2 diabetes: Insights from EXSCEL
6. Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF
7. Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure
8. Costs of care and financial hardship among patients with heart failure
9. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure
10. Improving Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: A Review of Implementation Strategies
11. The HFSA Advanced Heart Failure and Transplant Cardiology Fellowship Consensus Conference
12. Mineralocorticoid Antagonism in Heart Failure: Established and Emerging Therapeutic Role
13. Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial
14. Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper
15. Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial
16. Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System Inhibitors
17. Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3
18. High-Intensity Interval Training Versus Moderate Continuous Training in Patients With Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-analysis
19. Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure
20. Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America
21. Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event
22. Hand Grip Strength Predicts Mortality and Quality of Life in Heart Failure: Insights From the Singapore Cohort of Patients With Advanced Heart Failure
23. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society
24. A Roadmap to Reinvigorating Training Pathways Focused on the Care of Patients With Heart Failure: Shifting From Failure to Function
25. Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials
26. Practical Patient Care Considerations With Use of Vericiguat After Worsening Heart Failure Events
27. Vitamin D Levels in Black Americans and the Association With Left Ventricular Remodeling and Incident Heart Failure With Preserved Ejectin Fraction: The Jackson Heart Study
28. Do PRO Measures Function the Same Way for all Individuals With Heart Failure?
29. Physical activity and relationship to physical function, quality of life, and cognitive function in older patients with acute decompensated heart failure
30. Longitudinal Changes in Cardiac Troponin and Risk of Heart Failure Among Black Adults
31. Patient-reported and Clinical Outcomes Among Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction
32. Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel
33. Obesity Status and Physical Rehabilitation in Older Patients Hospitalized With Acute HF: Insights From REHAB-HF
34. Machine learning to define phenotypes and outcomes of patients hospitalized for heart failure with preserved ejection fraction: Findings from ASCEND-HF
35. A Randomized Controlled Trial of Mobile Health Intervention in Patients With Heart Failure and Diabetes
36. Trends in Heart Failure–Related Mortality Among Older Adults in the United States From 1999-2019
37. Donation After Circulatory Death in Heart Transplantation: History, Outcomes, Clinical Challenges, and Opportunities to Expand the Donor Pool
38. Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: Findings from the HF-ACTION trial
39. Prevalence and Prognostic Significance of Polyvascular Disease in Patients Hospitalized With Acute Decompensated Heart Failure: The ARIC Study
40. Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry
41. Emergency Department Visits Versus Hospital Readmissions Among Patients Hospitalized for Heart Failure
42. Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018
43. Sleep Breathing Disorders in Heart Failure
44. Spirituality in Patients With Heart Failure
45. Clinical trajectory of patients with a worsening heart failure event and reduced ventricular ejection fraction
46. Dysglycemia and incident heart failure among blacks: The jackson heart study
47. Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week
48. Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults
49. Physical Rehabilitation in Older Patients Hospitalized with Acute Heart Failure and Diabetes: Insights from REHAB-HF
50. Representativeness of the VICTORIA Trial Population in Clinical Practice: Analysis of the PINNACLE Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.